U.S. Pharmaceuticals & Biotech Mid-Large Cap Stocks

Stevanato Group

Market Cap: US$7.4b

Engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.

Pacira BioSciences

Market Cap: US$1.2b

Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.

Amphastar Pharmaceuticals

Market Cap: US$1.2b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

Medpace Holdings

Market Cap: US$14.0b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Exelixis

Market Cap: US$10.5b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Tempus AI

Market Cap: US$13.8b

Operates as a healthcare technology company.

Corcept Therapeutics

Market Cap: US$8.8b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Halozyme Therapeutics

Market Cap: US$8.8b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

Tilray Brands

Market Cap: US$1.4b

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.

ACADIA Pharmaceuticals

Market Cap: US$3.6b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

ADMA Biologics

Market Cap: US$3.7b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Biogen

Market Cap: US$20.2b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Sarepta Therapeutics

Market Cap: US$1.7b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

TG Therapeutics

Market Cap: US$5.2b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Intellia Therapeutics

Market Cap: US$1.9b

A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.

Illumina

Market Cap: US$14.5b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Adaptive Biotechnologies

Market Cap: US$2.0b

A commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

Kiniksa Pharmaceuticals International

Market Cap: US$2.7b

A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.

IDEAYA Biosciences

Market Cap: US$2.2b

A precision medicine oncology company, discovers and develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States.

CG Oncology

Market Cap: US$2.8b

A late-stage clinical biopharmaceutical company, develops and commercializes backbone bladder-sparing therapeutics for patients with bladder cancer.

United Therapeutics

Market Cap: US$19.8b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Rapport Therapeutics

Market Cap: US$1.2b

Operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders.

Dynavax Technologies

Market Cap: US$1.2b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.

Sionna Therapeutics

Market Cap: US$1.2b

A clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).

Beam Therapeutics

Market Cap: US$2.3b

A biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.

MoonLake Immunotherapeutics

Market Cap: US$3.4b

A clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases.

Mettler-Toledo International

Market Cap: US$25.6b

Manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.

Bausch Health Companies

Market Cap: US$2.5b

Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.

Wave Life Sciences

Market Cap: US$1.1b

A clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform.

Structure Therapeutics

Market Cap: US$1.5b

A clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.

Caris Life Sciences

Market Cap: US$8.6b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

Merus

Market Cap: US$5.2b

A clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands.

Viridian Therapeutics

Market Cap: US$1.6b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

Nuvation Bio

Market Cap: US$1.1b

A clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology.

Arcutis Biotherapeutics

Market Cap: US$2.1b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

Syndax Pharmaceuticals

Market Cap: US$1.3b

A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.